150 related articles for article (PubMed ID: 35222751)
1. Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation.
Osawa T; Mori H; Kawai A; Kawano D; Tsutsui K; Ikeda Y; Yamaga M; Sato A; Gatate Y; Hamabe A; Tabata H; Kato R; Matsumoto K
J Arrhythm; 2022 Feb; 38(1):58-66. PubMed ID: 35222751
[TBL] [Abstract][Full Text] [Related]
2. [Impact of different anticoagulation therapies on heparin dosage applied to atrial fibrillation patients undergoing atrial fibrillation catheter ablation].
Yang L; Gao LJ; Yin XM; Guo BL
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):602-607. PubMed ID: 31434430
[No Abstract] [Full Text] [Related]
3. Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.
Nogami A; Harada T; Sekiguchi Y; Otani R; Yoshida Y; Yoshida K; Nakano Y; Nuruki N; Nakahara S; Goya M; Origasa H; Kihara Y; Hirao K; Aonuma K;
JAMA Netw Open; 2019 Apr; 2(4):e191994. PubMed ID: 31002317
[TBL] [Abstract][Full Text] [Related]
4. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
Maddox W; Kay GN; Yamada T; Osorio J; Doppalapudi H; Plumb VJ; Gunter A; McElderry HT
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
[TBL] [Abstract][Full Text] [Related]
6. Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation.
Nakamura R; Okishige K; Shigeta T; Nishimura T; Kurabayashi M; Yamauchi Y; Sasano T; Hirao K
J Cardiol; 2019 Aug; 74(2):150-155. PubMed ID: 31029455
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation.
Aoyama D; Miyazaki S; Hasegawa K; Kaseno K; Ishikawa E; Mukai M; Miyahara K; Aiki T; Matsui A; Yamaguchi J; Shiomi Y; Tama N; Ikeda H; Fukuoka Y; Morishita T; Ishida K; Uzui H; Tada H
Int Heart J; 2019 Nov; 60(6):1315-1320. PubMed ID: 31735780
[TBL] [Abstract][Full Text] [Related]
8. Effect of uninterrupted dabigatran or rivaroxaban on achieving ideal activated clotting time to heparin response during catheter ablation in patients with atrial fibrillation.
Xin Q; Zhang C; Wang YJ; Li J; Chen T; Li SX; Wang W; Yang Y; Song WJ; Zhou J; Shi XM
J Geriatr Cardiol; 2022 Aug; 19(8):565-574. PubMed ID: 36339467
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vanga SR; Santangeli P; Swarup V; Pimentel R; Mansour MC; D'Avila A; Sanchez JE; Burkhardt JD; Chalhoub F; Mohanty P; Coffey J; Shaik N; Monir G; Reddy VY; Ruskin J; Natale A
J Am Coll Cardiol; 2012 Mar; 59(13):1168-74. PubMed ID: 22305113
[TBL] [Abstract][Full Text] [Related]
10. Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment.
Zhang RF; Ma CM; Wang N; Yang MH; Li WW; Yin XM; Dong YX; Yu XH; Xiao XJ; Xia YL; Gao LJ
BMC Cardiovasc Disord; 2021 Apr; 21(1):214. PubMed ID: 33906609
[TBL] [Abstract][Full Text] [Related]
11. Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study.
Tang L; Liu H; Deng H; Zhan X; Fang X; Liao H; Liu Y; Fu L; Fu Z; Liu H; Wu S; Xue Y
Front Med (Lausanne); 2020; 7():197. PubMed ID: 32582721
[No Abstract] [Full Text] [Related]
12. Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study.
Arshad A; Johnson CK; Mittal S; Buch E; Hamam I; Tran T; Shaw RE; Musat D; Preminger M; Sichrovsky T; Herweg B; Shivkumar K; Hummel J; Steinberg JS
Pacing Clin Electrophysiol; 2014 Jun; 37(6):665-73. PubMed ID: 24797604
[TBL] [Abstract][Full Text] [Related]
13. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin.
Konduru SV; Cheema AA; Jones P; Li Y; Ramza B; Wimmer AP
J Interv Card Electrophysiol; 2012 Dec; 35(3):277-84; discussion 284. PubMed ID: 23015216
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effectiveness and safety between uninterrupted direct oral anticoagulants with and without switching to dabigatran in atrial fibrillation ablation.
Harada M; Motoike Y; Nomura Y; Nishimura A; Koshikawa M; Murayama K; Ohno Y; Watanabe E; Izawa H; Ozaki Y
J Arrhythm; 2020 Jun; 36(3):417-424. PubMed ID: 32528566
[TBL] [Abstract][Full Text] [Related]
15. Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study.
Calkins H; Willems S; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Kleine E; Bis B; Gerstenfeld EP
Europace; 2019 Jun; 21(6):879-885. PubMed ID: 30982849
[TBL] [Abstract][Full Text] [Related]
16. Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study.
Bin Abdulhak AA; Kennedy KF; Gupta S; Giocondo M; Ramza B; Wimmer AP
J Interv Card Electrophysiol; 2015 Nov; 44(2):91-6. PubMed ID: 26292959
[TBL] [Abstract][Full Text] [Related]
17. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
[TBL] [Abstract][Full Text] [Related]
18. Catheter ablation for atrial fibrillation on uninterrupted direct oral anticoagulants: A safe approach.
Sawhney V; Shaukat M; Volkova E; Jones N; Providencia R; Honarbakhsh S; Dhillon G; Chow A; Lowe M; Lambiase PD; Dhinoja M; Sporton S; Earley MJ; Schilling RJ; Hunter RJ
Pacing Clin Electrophysiol; 2018 May; ():. PubMed ID: 29768672
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation.
Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
Intern Med; 2015; 54(10):1167-73. PubMed ID: 25986252
[TBL] [Abstract][Full Text] [Related]
20. How minimally interrupted direct oral anticoagulants affect intraprocedural anticoagulation during atrial fibrillation ablation? Insights from a Japanese single-center retrospective study.
Mizobuchi M; Funatsu A; Kobayashi T; Nakamura S
J Arrhythm; 2019 Oct; 35(5):716-724. PubMed ID: 31624510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
